Weight reduction can therefore improve symptoms and reduce disease activity in some patients
67,118,119 Beinaglutide, a recombinant human GLP-1 (rhGLP-1) polypeptide, exhibits a remarkable resemblance to human GLP-1(7-36), with nearly 100% homology
Demonstrate stability objectively Serial standardized photographs and trichoscopy are more reliable than reassurance based on a single visit
Medicare has historically not covered weight-loss-only indications, though the 2026 GLP-1 Bridge program provides temporary access to Foundayo at $50/month through December
* Noom Med program subscription includes telehealth services and access to Noom app educational, diet, exercise and support resources
What This May Mean for Patients None of this regulatory context is unique to altRx, and altRx itself is one of many telehealth platforms operating in this space